INDV

Indivior
INDV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$3.04B
EV
$2.90B
Shares Outstanding
124.77M
Beta
0.96

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$29.40
P/E 2025E
14.18x
P/Revenue 2025E
2.81x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Indivior PLC

gainify
INDV

Indivior PLC

INDV

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develo...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Ciaffoni, Joseph

Employees

1,000

IPO Date

2014-12-29

Headquarters

10710 Midlothian Turnpike, Suite 125, North Chesterfield, Virginia, 23235, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.